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ABSTRACT We describe a strategy for the cloning of
neurotransmitter-receptor and ion-channel cDNAs that is
based on electrophysiological assays of mRNA-injected Xeno-
pus oocytes. This procedure circumvents the purification of
these membrane proteins, which is hindered by their low
abundance and their hydrophobic nature. It involves methods
for RNA fractionation by high-resolution gel electrophoresis,
directional cDNA cloning in a single-stranded vector, and
screening of the cDNA library by voltage-clamp measurements
of currents induced by serotonin in mRNA-injected oocytes.
The applicability of our approach is demonstrated by the
isolation of a serotonin receptor cDNA clone from a mouse
choroid plexus papilloma. The clone was identified by hybrid-
depletion and hybrid-selection procedures. The receptor ex-
pressed in oocytes injected with hybrid-selected RNA is fully
functional, indicating that it is composed of a single subunit
encoded by a 5-kilobase RNA. The pharmacology of the
hybrid-selected receptor confirms that we have successfully
cloned a serotonin 5-HT1c receptor cDNA.
The neurotransmitter serotonin displays diverse psycholog-
ical and physiological effects in nervous tissues and in
smooth muscle (1). Serotonin receptors are targets for many
medications used in the treatment of psychiatric diseases and
of disorders related to smooth muscle tonus. Pharmacolog-
ical and electrophysiological studies indicate that there are at
least five kinds of serotonin binding sites in the rat and mouse
central nervous system. Following the original classification
into 5-HT1 and 5-HT2 receptors (2), four subtypes of the
5-HT1 binding sites, denoted 1A, 1B, 1C, and 1D, have been
characterized by pharmacological criteria in rat and mouse
brain (3-7). In addition, there are at least three 5-HT3 (M)
receptor types located in the peripheral nervous system (8).
Xenopus oocytes have been used to study neurotransmitter
receptors and ion channels expressed on the oocyte surface
after injection of mRNA isolated from electrically excitable
tissues. Only one type of serotonin binding site, the 5-HT1c
receptor, induces measurable conductances in Xenopus
oocytes injected with RNA isolated from rat or mouse brain
(9). The receptor couples to an oocyte guanine nucleotide
binding protein (G protein) and stimulates a Ca-activated
Cl-channel, presumably via phosphatidylinositol hydrolysis
(10, 11). A single 5- to 6-kilobase (kb) size class of poly(A)+
RNA isolated from rat brain is sufficient to generate the
serotonin response in the oocytes (9). The mRNA coding for
the 5-HTlC subtype is especially enriched in choroid plexus
(9). The epithelial cell layer of this tissue possesses the
highest known density of 5-HT1c receptors (5, 6).
Earlier we proposed the use of the oocyte expression
system for cloning ion channel or neurotransmitter receptor
cDNAs in those cases for which the conventional approach
through protein purification is not readily applicable (12).
Here, we report techniques developed for the enrichment of
RNAs coding for low-abundance receptors or ion channels,
followed by the construction of libraries containing cDNA
directionally inserted in single-stranded vectors. A method is
presented for screening cDNA libraries by hybrid depletion
using voltage-clamp measurements on oocytes. We have
applied this approach to the serotonin 5-HT1c receptor which
has not yet been purified and for which antibodies or protein
sequence data are not available. We used RNA isolated from
choroid plexus tumors that develop spontaneously in trans-
genic mice (strain SV11) carrying copies of the simian virus
40 early region (13, 14). A cDNA library was constructed
from tumor RNA enriched for the 5-HT1c receptor RNA by
size fractionation using gel electrophoresis. A screening
procedure based on electrophysiological tests of mRNA-
injected Xenopus oocytes was then used for the isolation of
a cDNA clone for the 5-HT1c receptor.
MATERIALS AND METHODS
mRNA Isolation and Size Fractionation. Choroid plexus
tumors were dissected from SV11 mice (14), quick frozen in
liquid nitrogen, and stored at - 80°C. The frozen tumors were
homogenized in 6 M guanidine hydrochloride/0.2 M NaOAc,
pH 5.1/100 mM 2-mercaptoethanol, and RNA was isolated
by a modification of the procedure of Chirgwin et al. (15). For
the size fractionation, 20 ,ug of poly(A)+ RNA was separated
on a vertical 0.8% agarose gel (Bio-Rad, ultrapure) as
described (16); however, some modifications were necessary
to achieve good resolution of biologically active, high mo-
lecular weight RNA. The gel contained 5 mM CH3HgOH
(AESAR, Johnson & Matthey, Seabrook, NH) and was
buffered with 0.1 M boric acid/5 mM Na2B407 10H20/0.3
mM EDTA. The RNA was disaggregated in 80% recrystal-
lized formamide for 2 min at 65°C, cooled on ice, and then
one-third volume of a solution containing 50 mM CH3HgOH,
4x gel buffer, 40% (wt/vol) glycerol, and 0.05% bromophe-
nol blue was added before loading (slot size: 0.4 cm x 4 cm).
Preelectrophoresis (30 min) and electrophoresis were per-
formed at 5-6 V/cm at 4°C. RNA was electroeluted from gel
slices into NH4OAc/sucrose step gradients in a modification
of the procedure described by Saha et al. (17). Then it was
recovered from the high-salt boundary and precipitated with
ethanol several times. Analysis of the fractionated RNA by
electrophoresis through an agarose gel containing formalde-
Abbreviations: 5-HT1_3 receptors, serotonin binding sites; G pro-
teins, guanine nucleotide binding proteins.
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hyde, blotting to nitrocellulose, and hybridization with a
poly(dT) probe were performed as described (9).
Xenopus Oocyte Injection and Electrophysiology. Detailed
protocols for the preparation and injection of the oocytes and
the electrophysiology have been described (9).
cDNA Library Construction. For the cDNA synthesis,
about 100 ng of highly enriched, size-selected RNA was
heated to 65TC for 2 min, mixed with 0.85 gg of phosphoryl-
ated oligonucleotide primer (pGCAGGTCGACTCTAGAT-
TTTTT T) and 8.5 units of reverse transcriptase (RAV 2,
Amersham), and incubated for 1 hr at 420C (10-il reaction
volume) using the buffer conditions described (18). The
primer contains an Xba I restriction site, which is retained in
the final construct and may facilitate further analysis. The
reaction was stopped by addition of 3 Al of 0.25 M EDTA, 4
,ul of H20, and 3 ,ul of 1 M NaOH. After RNA hydrolysis for
30 min at 60TC, 1 ul of 1 M HCl was added, and the cDNA
was size-selected and separated from unincorporated primer
and free nucleotides by two passes over a 1-ml Sepharose
CL-4B (Sigma) column equilibrated in 30 mM NaOH/2 mM
EDTA to keep the single-stranded cDNA extended. The
excluded volume of the second passage was concentrated by
extraction with 2-butanol, and the cDNA was precipitated
with ethanol, washed twice with 75% ethanol, and dried
lightly. For the subsequent G-tailing (18), the cDNA was
incubated for 1 hr at 37°C in 0.2 M sodium cacodylate, pH
6.9/1 mM CoCl2/0.9 mM dGTP/500 units of terminal trans-
ferase (Pharmacia) per ml. The reaction was stopped by
adjusting the mixture to 25 mM EDTA and heating for 10 min
at 70°C.
The vector pUC119 (19) was digested with Kpn I, C-tailed
in 0.2 M sodium cacodylate, pH 6.9/1 mM CoCl2/0.9 mM
dCTP/1000 units of terminal transferase per ml for 90 sec at
15°C, and digested with Pst I. The small fragment was
removed by gel filtration on a 5-ml Bio-Rad A-50m column.
The excluded volume from this column was extracted with
phenol/CHCl3 and precipitated with ethanol twice.
The G-tailed cDNA was twice precipitated together with 1
,ug of this vector as carrier and dissolved in 50 ,l of annealing
buffer (0.01 M Tris HCl, pH 8/1 mM EDTA/0.15 M NaCl)
containing 0.5 ,ug of a phosphorylated oligonucleotide
(pTCTAGAGTCGACCTGCTGCA) complementary to the
first-strand primer. The mixture was heated to 70°C for 5 min
and then incubated sequentially for 20 min at 58°C, 15 min at
48°C, and 30 min at 37°C. Afterwards, the DNA was ligated
in 500 ,ul with 1600 units of T4 DNA ligase (New England
Biolabs) under standard conditions for 15 hr at 15°C. The
mixture was then twice extracted with phenol/CHCl3, con-
centrated by extraction with 2-butanol and precipitated with
ethanol. The gap-filling reaction was performed for 5 hr at
15°C and for 1 hr at 22°C in a 50-,l volume with 24 units of
DNA polymerase I (Amersham) and 10 units of Esherichia
coli DNA ligase (New England Biolabs) as described (18).
The DNA was diluted 1:20 with H20 and transformed into E.
coli R4 (20) by a modification of the Hanahan procedure (21).
Preparation of Single-Stranded DNA. A logarithmically
growing culture of bacteria carrying the pUC119 plasmid
(OD550 < 0.1) was infected with 2-10 plaque-forming units per
cell M13K07 (19). About 1 hr after infection, the culture was
adjusted to contain 70 ,ug of kanamycin per ml. The phage
was harvested 6-12 hr later, and single-stranded DNA was
isolated as described for phage M13 (22).
Hybrid Depletion. To achieve optimal hybridization kinet-
ics, the single-stranded DNA was linearized as follows. A
22-base oligonucleotide complementary to the EcoRI cleav-
age site in the polylinker was annealed to the single-stranded
DNA, which was then digested with EcoRI. The linear
single-stranded DNA was hybridized at 65°C with 20 ,ug of
RNA in 50 /l of reaction mixture containing 1 M NaCl, 50
mM sodium phosphate (pH 6.5), 2 mM EDTA, and 15 jzg of
poly(dA) (Sigma). Pools of 20 clones were tested at a total
DNA concentration of 1 mg/ml. After hybridization, the
nucleic acid components were separated by centrifugation on
a density gradient (128 g of CsCl and 24 g of guanidine
hydrochloride added to 100 ml of 20 mM NaOAc, pH 5.2/1
mM EDTA) in a VTI 65.2 rotor at 55,000 rpm and 16'C for 7
hr. The RNA was purified by three precipitations with
ethanol and dissolved in 10 ,ul of H20 for oocyte injections.
Hybrid Selection. Nitrocellulose filters (Schleicher &
Schuell, 9 mm) were loaded with 30 ,.g of linearized single-
stranded DNA as described (23). Prehybridizations were
performed for 12 hr at 450C in 200 1.d containing 70%
formamide, 0.4 M NaCl, 50 mM sodium phosphate (pH 6.5),
1 mM EDTA, 25 ,gg of poly(dA), 25 tkg of poly(rC) (Sigma),
and 0.4 mg of yeast RNA (Sigma, type III) per ml. For
hybridizations, 100 dul of the same buffer was used, but the
yeast RNA was replaced by 30 jig of total RNA isolated from
choroid plexus tumors, and the incubation was continued at
45°C for 4.5 hr. Unhybridized RNA was then precipitated
twice with ethanol. The filters were incubated for an addi-
tional 15 min at 45°C in the same buffer containing poly(dA)
and poly(rC) but no mRNA. Afterwards, they were rinsed
quickly and washed three times for 3 min at 55°C in 0.015 M
NaCl/0.0015 M sodium citrate, pH 7/0.1% NaDodSO4.
Elution of hybridized RNA was performed as described (23).
For the injections, unhybridized RNA was dissolved in 20 ,ul
of H20, and eluted RNA, in 5 ul.
RESULTS
RNA Fractionation. The typical two-component Cl-cur-
rents induced by serotonin in Xenopus oocytes injected with
RNA isolated from mouse brain and choroid plexus tumors
are shown in Fig. 1 A and B, respectively. Tumors of the
epithelial cell layer in choroid plexi from SV11 mice (14) have
a 5-HTic binding site density of 6.6 pmol/mg of microsomal
protein (24). This is about twice as high as that in rat choroid
plexus and several-fold higher than in larger animals, which
could provide greater amounts of tissue (6). Based on the site
density, we estimate that even in the choroid plexus tumors
there is only 1 serotonin binding site per 60,000 protein
molecules, an abundance that may be reflected on the RNA
level. Therefore, the receptor RNA should be highly enriched
A B c
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FIG. 1. Serotonin-evoked Cl-currents in Xenopus oocytes.
Oocytes from the same frog were injected with 50 ng of poly(A)+
RNA isolated from mouse cortex and midbrain (A), with 25 ng of total
RNA isolated from choroid plexus tumors (B), or with RNA that was
hybrid-selected with clone D9 (C). Currents were recorded with a
two-electrode voltage clamp at a holding potential of -70 mV. Bars
indicate the duration of agonist (1 /AM serotonin) application.
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prior to construction of a library in order to reduce the
number of clones that have to be tested.
Twenty micrograms of tumor poly(A)+ RNA was enriched
for the serotonin receptor RNA by high-resolution gel frac-
tionation, which allows more accurate sizing and better
enrichment of biologically active RNA than does velocity
sedimentation. A single RNA fraction of 4.8-5.2 kb was
sufficient for generating the serotonin response in injected
oocytes (Fig. 2), as found previously with RNA isolated from
rat brain (9). We recovered about 100 ng ofRNA in the active
fraction.
Selection Procedure. The specific requirements for the
identification of a positive clone would determine the strategy
for constructing an appropriate cDNA library. Hybrid de-
pletion can be used even if a receptor or channel is composed
of several subunits, while hybrid selection can only be used
for single-subunit proteins. Since in our hands membrane
filter hybridizations are slower and less efficient, we wished
to hybridize RNA to its cDNA in solution and then to
separate RNA from DNA and from DNARNA hybrids. This
separation was best accomplished by using a CsCl gradient
containing guanidine hydrochloride to reduce the density of
nucleic acids (25). The gradient was adjusted so that RNA
banded close to the bottom of the tube while DNA floated at
the top. Banding of RNA caused significantly less degrada-
tion than did pelleting (our unpublished results). Under
appropriate conditions, an RNA should hybridize completely
to its cDNA clone and band in the middle of the gradient as
a DNA-RNA hybrid, leaving the RNA band depleted of this
specific RNA. If a cDNA clone coding for a channel or
receptor were present in the hybridization pool, then injec-
tion of the depleted RNA from the gradient should result in
a reduced electrical response in the oocytes. To test this idea,
a 750-bp cDNA of the voltage-gated Na-channel cloned in
phage M13 (23) was hybridized for 30 min with RNA at a
DNA concentration of 50 gg/ml, and the nucleic acid
c
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FIG. 2. Tumor RNA fractionation. (Left) Poly(A)+ RNA (20 ,"g)
isolated from choroid plexus tumors was size-fractionated on an
agarose gel containing CH3HgOH. Oocytes were injected with 0.1%
of each RNA fraction, and serotonin responses were recorded. The
low agonist concentration was chosen to avoid saturation of the
response (9). (Right) To analyze the size distribution of the fraction-
ated mRNA, 2.5% of each fraction was separated on a formaldehyde
gel, blotted to nitrocellulose and hybridized with a 32P-labeled
poly(dT) probe (9). Higher and lower molecular length fractions are
not shown.
components were separated in the density gradient. In the
oocytes, the voltage-clamp currents generated by injection of
the hybrid-depleted RNA were about 10% of those induced
by the control RNA hybridized to M13 vector DNA only
(data not shown).
Generation of a cDNA Library. We wanted to construct a
cDNA library in a way that would facilitate the selection
procedure described above. The vector pUC119 allows the
formation of single-stranded DNA after infection with the
M13K07 helper phage (19). The directional cDNA cloning
strategy (Fig. 3) is designed such that the single-stranded
plasmids contain cDNA inserts in the antisense orientation.
These inserts can be hybridized to their complementary
RNAs without complications from DNADNA reassociation.
This method permits a high cloning efficiency and a high
frequency of inserts because excess vector can be used with
minute amounts of cDNA (26). The cDNA can be size-
selected before directional insertion into the vector. In
addition, the length of cDNA inserts is not compromised by
the presence of any particular restriction site within the
insert. Using this approach, we obtained about 35,000 indi-
vidual colonies from 100 ng ofhighly size-selected 5-kb RNA.
Identification of a 5-HTlc Receptor cDNA Clone. To reduce
the number of clones to be considered, the library was
prescreened by a subtractive hybridization with 32P-labeled
kidney cDNA. This tissue was chosen for the functional and
structural similarity of renal tubule epithelia with choroid
plexus epithelia. Injection of kidney poly(A)+ RNA did not
trigger a serotonin response in oocytes. Clones that hybrid-
ized with the kidney cDNA (about 25% of the library) were
excluded from further screening. To minimize differences in
the representation of individual clones, single-stranded
DNAs were prepared from groups of 10 clones and 2 groups
were pooled for testing. They were then hybridized to total
choroid plexus tumor RNA, and those testing positive were
rescreened and eventually subdivided until an individual
positive clone was identified. From 1200 colonies tested, we
have isolated 1 clone that tested positive in several indepen-
dent hybrid-depletion experiments. In the experiment shown
in Table 1, experiment A, RNA bands were recovered from
density gradients after hybridization with individual clones.
For clone D9, the serotonin response in oocytes injected with
this hybrid-depleted RNA was <20% of that seen with the
other clones. When the RNA-DNA hybrids recovered from
the middle of the same gradients were injected into oocytes,
the serotonin response was at least 10-fold greater for clone
D9 than for clones El, E3, or E4 (Table 1, experiment B).
Addition of excess poly(rC) to the hybridization mix had no
influence on this result, indicating that it is not caused by
nonspecific binding of the dG homopolymer present in the
single-stranded DNA (data not shown). For the experiment
shown in Table 1, total RNA from choroid plexus tumors was
used because of the relatively high abundance of 5-HT1c
receptor RNA in this tissue and the resulting large serotonin-
induced conductances in the oocytes. However, we knew of
no other electrophysiological response triggered by choroid
plexus RNA to serve as an internal control (9). Therefore, we
performed a similar experiment with poly(A)+ RNA isolated
from the cortices and midbrains of 14-day-old C57BL mice
(Table 2, experiment A). RNA that was hybrid-depleted with
clone D9 generated greatly decreased serotonin responses in
the oocytes, while the kainate response and the voltage-
activated sodium current were unaffected. Again, addition of
poly(rC) to the hybridization mix had no influence on this
result (data not shown).
In addition to the hybrid selection shown in Table 1,
experiment B, we used the standard procedure for hybrid
selection with DNA bound to nitrocellulose filters. The rather
stringent hybridization and washing conditions were chosen
to decrease nonspecific binding and thus to avoid a back-
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FIG. 3. Directional cDNA cloning strategy. For details, see Materials and Methods and Results.
ground response in the oocytes. The experiment shows that
the RNA coding for the serotonin receptor hybridized selec-
tively with clone D9 (Table 2, experiment B, hybridized). For
the other clones tested, the RNA remained in the hybridiza-
tion solution (not hybridized). Taking the results of these
hybrid-depletion and hybrid-selection experiments together,
we conclude that we have identified a cDNA clone that
hybridizes with serotonin receptor mRNA.
Characterization of the Clone. The serotonin-induced con-
ductances in Xenopus oocytes injected with rat brain RNA
display 5-HT1c pharmacology (9). In addition, 5-HT1c is the
only identified serotonin receptor type in choroid plexus
tumors (24). To confirm the subtype of the hybrid-selected
receptor, we performed a simple pharmacological character-
Table 1. Identification of a serotonin receptor clone
Voltage-clamp currents in oocytes after injection of
RNA tested with individual clones, nA
Exp. El E3 E4 D9
A 581 ±63 562 ± 176 626 + 121 99 ± 23
B 22.5 18 16 16 0 260 ± 87
Single-stranded DNA (500 ,g/ml) from several individual clones
was hybridized with 20,g oftumor RNA. RNAs (experiment A) and
DNA-RNA hybrids (experiment B) were separated on density
gradients and injected into oocytes. Responses to 20 nM (experiment
A) or 50 nM (experiment B) serotonin were recorded. Values are
means ± SEM from several independent experiments.
ization. The response waveforms in oocytes injected with
RNA that was hybrid-selected with clone D9 resemble those
of oocytes injected with RNA isolated from mouse brain or
Table 2. Hybrid depletion of mouse brain (experiment A) and
hybrid selection of tumor RNA (experiment B)
Voltage-clamp currents in oocytes
after injection of RNA tested with
individual clones, nA
Experiment El D9 D10
A Na current 567 ± 95 575 ± 86 492 ± 108
Kainate (0.1 mM) 300 ± 45 283 ± 29 308 ± 41
Serotonin (20 nM) 1014 ± 103 80 + 24 1064 ± 114
B Hybridized 0 495 78 9 ± 5
Not hybridized 1750 ± 238 469 ± 66 1975 ± 250
In experiment A, 25 Ag of mouse cortex and midbrain poly(A)+
RNA was hybridized with single-stranded cDNA (250 ,ug/ml) from
individual clones for 75 min, followed by density gradient separation,
Hybrid-depleted RNAs were injected into oocytes, and voltage-
clamp currents were measured. In experiment B, choroid plexus
tumor RNA was hybrid-selected with DNA from cDNA clones.
RNAs eluted from the filters (hybridized) and RNAs remaining in the
hybridization solution (not hybridized) were injected into oocytes,
and the responses to 1 ,iM (hybridized) or 50 nM serotonin (not
hybridized) were recorded. Values in both experiments A and B are
the means ± SEM of two independent experiments with several
oocytes each.
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from choroid plexus tumors (Fig. 1). A response to 0.1 gM
serotonin was greatly reduced by 0.25 ,uM mianserin and only
slightly affected by 5 gM spiperone (data not shown),
corresponding to apparent Ki values of <80 nM for mianserin
and > 1700 nM for spiperone (27). Together with the
nanomolar affinity for serotonin, this indicates that, indeed,
we have cloned a cDNA for the 5-HT1c receptor type (9). The
clone contains a 1.9-kb cDNA and, as determined by RNA
blot analysis, hybridizes to a 5-kb RNA species in RNAs
isolated from choroid plexus tumors or mouse brain (data not
shown).
DISCUSSION
We have developed a strategy for cloning neurotransmitter-
receptor and ion-channel cDNAs even though they are
expressed at low abundances. This approach is designed for
those cases in which generally used tools for molecular
cloning such as antibodies or oligonucleotide probes based on
protein sequence data are not available. It involves high-
resolution RNA fractionation, directional cDNA library con-
struction, and library screening using the oocyte electrophys-
iological assay. In the design of these methods, our emphasis
has been on the maintenance of the biological activity of very
large RNAs. Clone isolation by hybrid arrest, using the
density gradient separation procedure, is effective even if
several subunits are necessary for receptor or iqn-channel
function. This method uses the advantages of solution hy-
bridization and circumvents the uncertainties involved in
procedures such as antisense RNA orDNA injections that do
not appear to block the translation consistently for every
RNA (our unpublished results).
We have applied our approach to the cloning of a serotonin
5-HT1c receptor cDNA. With the isolated clone, serotonin
receptor mRNA can be specifically removed from the RNA
band in a density gradient and relocated to the position of
DNARNA hybrids. Furthermore, the cloned cDNA bound
to nitrocellulose hybridizes specifically with the receptor
mRNA. The identity of the receptor type was confirmed by
a pharmacological characterization of the receptor expressed
in oocytes injected with hybrid-selected RNA. This RNA
encoded a fully functional receptor, which indicates that only
one receptor subunit is necessary for function, similar to the
muscarinic Ml and the 8-adrenergic receptors. These recep-
tors are also coupled to G proteins (28, 29). The clone
hybridizes with only one RNA band on aRNA blot and gives
a simple pattern on a Southern blot consistent with a single
gene (data not shown), indicating that indeed we have cloned
a portion of the gene coding for the serotonin 5-HT1c
receptor.
Although the existence of several serotonin receptor types
in the brain and in peripheral tissues is well documented
(2-8), no 5-HT receptor type has been purified yet. Our
partial-length cDNA insert should enable us to obtain a
full-length clone for the 5-HTlc receptor and possibly to
isolate clones for other 5-HT receptor types by cross-
hybridization. The isolation and analyses of 5-HT receptor
clones should contribute to understanding the structure and
function as well as the observed diversity of serotonin
receptors.
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